These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32868683)

  • 1. Gut microbial dysbiosis as a limiting factor in the management of primary and secondary sarcopenia: an Asian Indian perspective.
    Bhattacharya S; Bhadra R; Schols AMWJ; Sambashivaiah S
    Curr Opin Clin Nutr Metab Care; 2020 Nov; 23(6):404-410. PubMed ID: 32868683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia.
    Picca A; Fanelli F; Calvani R; Mulè G; Pesce V; Sisto A; Pantanelli C; Bernabei R; Landi F; Marzetti E
    Mediators Inflamm; 2018; 2018():7026198. PubMed ID: 29686533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.
    Nishikawa H; Enomoto H; Nishiguchi S; Iijima H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota.
    Maslennikov R; Alieva A; Poluektova E; Zharikov Y; Suslov A; Letyagina Y; Vasileva E; Levshina A; Kozlov E; Ivashkin V
    World J Gastroenterol; 2023 Jul; 29(27):4236-4251. PubMed ID: 37545638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Lifestyle and Diet on Gut Microbiota Composition, Inflammation and Muscle Performance in Our Aging Society.
    Strasser B; Wolters M; Weyh C; Krüger K; Ticinesi A
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease.
    Haran JP; McCormick BA
    Gastroenterology; 2021 Jan; 160(2):507-523. PubMed ID: 33307030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The leaky gut and the gut microbiome in sepsis - targets in research and treatment.
    Chancharoenthana W; Kamolratanakul S; Schultz MJ; Leelahavanichkul A
    Clin Sci (Lond); 2023 Apr; 137(8):645-662. PubMed ID: 37083032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of uremic dysbiosis to insulin resistance and sarcopenia.
    Uchiyama K; Wakino S; Irie J; Miyamoto J; Matsui A; Tajima T; Itoh T; Oshima Y; Yoshifuji A; Kimura I; Itoh H
    Nephrol Dial Transplant; 2020 Sep; 35(9):1501-1517. PubMed ID: 32535631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and physical frailty through the mediation of sarcopenia.
    Casati M; Ferri E; Azzolino D; Cesari M; Arosio B
    Exp Gerontol; 2019 Sep; 124():110639. PubMed ID: 31226349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related sarcopenia and altered gut microbiota: A systematic review.
    Wang M; Ren F; Zhou Y; He Y; Du T; Tan Y
    Microb Pathog; 2024 Oct; 195():106850. PubMed ID: 39142365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intestinal microbiome and its relevance for functionality in older persons.
    Ticinesi A; Tana C; Nouvenne A
    Curr Opin Clin Nutr Metab Care; 2019 Jan; 22(1):4-12. PubMed ID: 30489399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of synbiotic and/or vitamin D supplementation on gut-muscle axis in overweight and obese women: a study protocol for a double-blind, randomized, placebo-controlled trial.
    Jamshidi S; Masoumi SJ; Abiri B; Vafa M
    Trials; 2022 Aug; 23(1):631. PubMed ID: 35927757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on Impact of dietary interventions, drugs, and traditional herbal supplements on the gut microbiome.
    Karim MR; Iqbal S; Mohammad S; Lee JH; Jung D; Mathiyalagan R; Yang DC; Yang DU; Kang SC
    Microbiol Res; 2023 Jun; 271():127346. PubMed ID: 36921399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critical role of gut microbiota dysbiosis in skeletal muscle wasting: a systematic review.
    Nikkhah A; Ejtahed HS; Ettehad Marvasti F; Taghavi M; Pakmehr A; Hajipour F; Larijani B
    J Appl Microbiol; 2023 Jan; 134(1):. PubMed ID: 36626794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota in common elderly diseases affecting activities of daily living.
    Shimizu Y
    World J Gastroenterol; 2018 Nov; 24(42):4750-4758. PubMed ID: 30479462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism.
    Anto L; Blesso CN
    J Nutr Biochem; 2022 Jul; 105():108991. PubMed ID: 35331903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
    Yurtdaş G; Akdevelioğlu Y
    J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia.
    Ticinesi A; Nouvenne A; Cerundolo N; Catania P; Prati B; Tana C; Meschi T
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31319564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut-Muscle Axis?
    Ticinesi A; Lauretani F; Milani C; Nouvenne A; Tana C; Del Rio D; Maggio M; Ventura M; Meschi T
    Nutrients; 2017 Nov; 9(12):. PubMed ID: 29189738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota in relation to frailty and clinical outcomes.
    D'Amico F; Barone M; Brigidi P; Turroni S
    Curr Opin Clin Nutr Metab Care; 2023 May; 26(3):219-225. PubMed ID: 36942920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.